Xian Xice Testing Technology Co. Ltd. A (301306) fair value: what the stock is really worth
We calculate from audited financials what Xian Xice Testing Technology Co. Ltd. A is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jun 24, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Xian Xice Testing Technology Co. Ltd. A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 24, 2026.
How to read this chart
50‑month range ¥20.12 – ¥179.38 · fair‑value band ¥35.18 – ¥58.64 · the ¥96.38 price screens above the ¥46.91 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jun 24, 2026.
Follow Xian Xice Testing Technology Co. Ltd. A in your weekly email
Every Wednesday you see whether Xian Xice Testing Technology Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Xi'an Xice Testing Technology Co., Ltd. provides testing services in China. The company offers inspection and testing of military equipment and civil aircraft products, environmental and reliability test, electronic component detection and screening, electromagnetic compatibility test, and sells testing equipment and electrical equipment business.
Show more
Xi'an Xice Testing Technology Co., Ltd. provides testing services in China. The company offers inspection and testing of military equipment and civil aircraft products, environmental and reliability test, electronic component detection and screening, electromagnetic compatibility test, and sells testing equipment and electrical equipment business. Its services cover aerospace, aviation, weapons, ships, electronic components, and civil aircraft industries and fields. The company was founded in 2010 and is based in Xi'an, China.
Stock analysis
Xian Xice Testing Technology Co. Ltd. A (301306) currently trades at ¥96.38, while our model-based Fair Value estimate is ¥46.91, implying the stock looks roughly 105.5% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 92/100, which puts the evidence level at low.
Scenario range: ¥35.18 (bear) to ¥58.64 (bull), the price of ¥96.38 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Industrials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Xian Xice Testing Technology Co. Ltd. A reported revenue of 324M CNY in FY2025 versus 246M CNY in FY2021, a compound +7.2%/yr. Reported net income was −130M CNY in FY2025.
Key figures
Market cap 11.9B CNY (≈ $1.8B) · P/S ratio 38.4 · EPS (TTM) ¥−1.76 · Dividend yield 0.1% · Net margin −40.2% · Return on equity −15.5% · Return on assets (EBIT) 1.7% · Operating margin −51.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 46% below its 52-week high and 90% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −20% fair-value upside, at −51%, 301306 screens richer than that median.
Fair Value models
Bear ¥35.18Fair Value ¥46.91Bull ¥58.64
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.23/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−16.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.9%
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
29.2% (2019) → −27.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Xian Xice Testing Technology Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Aerospace & Defense · 228 stocks
Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score43 · Below median
Fair Value upside−51% · Below median
Profitability
Return on assets−5% · Bottom 25%
Net margin (TTM)−48% · Bottom 25%
Operating margin (TTM)−52% · Bottom 25%
Growth and dividend
Revenue growth−20% · Bottom 25%
Dividend yield (TTM)0.1% · Bottom 25%
Balance sheet
Debt / equity0.35× · Above median
Valuation Multiplesvs Aerospace & Defense median · lower = cheaper
P/B2.01× · Cheaper than median
P/S (TTM)5.74× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 47
PAST (return on equity)0· sector 38
HEALTH (low debt)83· sector 93
DIVIDEND (yield)1· sector 17
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Xian Xice Testing Technology Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/301306
Frequently asked questions
Is Xian Xice Testing Technology Co. Ltd. A (301306) overvalued or undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥46.91 versus a price of ¥96.38, about −51% upside (overvalued).
What is the fair value of 301306?
Our model-based fair value for Xian Xice Testing Technology Co. Ltd. A is ¥46.91 (as of Jun 24, 2026), built from audited fundamentals. The current price: ¥96.38.
What is the quality score of 301306?
Xian Xice Testing Technology Co. Ltd. A has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xian Xice Testing Technology Co. Ltd. A (301306)?
Our model-based price target is the fair value of ¥46.91 (as of Jun 24, 2026) from 1 valuation models. Cautious scenario ¥35.18, optimistic scenario ¥58.64. It is a calculation from audited fundamentals, not an analyst target.
What is the Xian Xice Testing Technology Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥46.91, about −51% upside versus a price of ¥96.38 (overvalued). Cautious scenario ¥35.18, optimistic scenario ¥58.64. The calculation is refreshed regularly with new filings.
What is the revenue of Xian Xice Testing Technology Co. Ltd. A (301306)?
Xian Xice Testing Technology Co. Ltd. A reported trailing-twelve-month revenue of about 308M CNY (latest available figure, as of Jun 24, 2026).
Does Xian Xice Testing Technology Co. Ltd. A pay a dividend?
Xian Xice Testing Technology Co. Ltd. A currently shows a dividend yield of about 0.07% relative to its recent price (as of Jun 24, 2026).
What is the intrinsic value of Xian Xice Testing Technology Co. Ltd. A (301306)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xian Xice Testing Technology Co. Ltd. A it is ¥46.91 per share (as of Jun 24, 2026), against a price of ¥96.38. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Xian Xice Testing Technology Co. Ltd. A stock overvalued or undervalued in 2026?
As of Jun 24, 2026, 301306 trades above its calculated fair value: price ¥96.38, fair value ¥46.91, a gap of about −51% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301306?
No. The price is what the market pays today (¥96.38); the fair value is what the company's own numbers justify (¥46.91). For Xian Xice Testing Technology Co. Ltd. A the two are ¥49.47 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xian Xice Testing Technology Co. Ltd. A worth?
The market values Xian Xice Testing Technology Co. Ltd. A at about 11.9B CNY (market capitalisation, as of Jun 24, 2026). Per share that is ¥96.38; our models calculate a fair value of ¥46.91 per share.
What do the bullish and bearish scenarios say about 301306?
Our models span a range for Xian Xice Testing Technology Co. Ltd. A: cautious scenario ¥35.18, base ¥46.91, optimistic ¥58.64 per share (as of Jun 24, 2026, price ¥96.38). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Xian Xice Testing Technology Co. Ltd. A (301306)?
Balance-sheet figures for Xian Xice Testing Technology Co. Ltd. A (as of Jun 24, 2026): return on equity −15.5%, debt of 0.35 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 301306 from its 52-week high?
Xian Xice Testing Technology Co. Ltd. A trades at ¥96.38, about 46% below its 52-week high of ¥179.38 and 90% above the low of ¥50.86 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥46.91 is for.
Which stocks are comparable to Xian Xice Testing Technology Co. Ltd. A?
From the same area (Industrials) we also value General Electric Company, RTX Corporation, Airbus SE, Safran SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xian Xice Testing Technology Co. Ltd. A stock attractive at the current price?
The data as of Jun 24, 2026: price ¥96.38, calculated fair value ¥46.91 (−51%), Quality Score 43/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301306 calculated?
We run Xian Xice Testing Technology Co. Ltd. A through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥46.91, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Xian Xice Testing Technology Co. Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xian Xice Testing Technology Co. Ltd. A (301306)?
The closing price on Sep 22, 2026 was ¥96.38. Our model-based fair value is ¥46.91, about −51% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xian Xice Testing Technology Co. Ltd. A right now?
The price sits above even our optimistic bull case (¥58.64). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Xian Xice Testing Technology Co. Ltd. A
How large is the market capitalisation of Xian Xice Testing Technology Co. Ltd. A (301306)?
The market capitalisation of Xian Xice Testing Technology Co. Ltd. A is 11.9B CNY (≈ $1.8B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xian Xice Testing Technology Co. Ltd. A (301306)?
The price-to-sales ratio of Xian Xice Testing Technology Co. Ltd. A is 38.4 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xian Xice Testing Technology Co. Ltd. A (301306)?
Earnings per share at Xian Xice Testing Technology Co. Ltd. A are ¥−1.76. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Xian Xice Testing Technology Co. Ltd. A (301306)?
The dividend yield of Xian Xice Testing Technology Co. Ltd. A is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Xian Xice Testing Technology Co. Ltd. A (301306)?
The net margin of Xian Xice Testing Technology Co. Ltd. A is −40.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Xian Xice Testing Technology Co. Ltd. A (301306)?
The return on equity (ROE) of Xian Xice Testing Technology Co. Ltd. A is −15.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xian Xice Testing Technology Co. Ltd. A (301306)?
On an EBIT basis the return on assets of Xian Xice Testing Technology Co. Ltd. A is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xian Xice Testing Technology Co. Ltd. A (301306)?
The operating margin of Xian Xice Testing Technology Co. Ltd. A is −51.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xian Xice Testing Technology Co. Ltd. A (301306)?
Revenue at Xian Xice Testing Technology Co. Ltd. A is growing −20.2% versus a year earlier (3y avg +2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Xian Xice Testing Technology Co. Ltd. A (301306)?
Earnings per share at Xian Xice Testing Technology Co. Ltd. A are growing +58.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Xian Xice Testing Technology Co. Ltd. A (301306) generate?
The free cash flow of Xian Xice Testing Technology Co. Ltd. A is −212M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Xian Xice Testing Technology Co. Ltd. A (301306) carry?
The net debt of Xian Xice Testing Technology Co. Ltd. A is 162M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Xian Xice Testing Technology Co. Ltd. A in the live analysis
One click puts Xian Xice Testing Technology Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
